The prevalence of diabetes is increasing due to aging of the population and increasing obesity.
INTRODUCTION
With increasing aging of the population and changes in lifestyle, the prevalence of diabetes is likely to increase, especially among individuals aged C75 years. Diabetes is associated with premature morbidity, mortality, and is a substantial health burden on individuals, health systems, and society. Diabetes is the seventh-leading cause of death in the US mainly due to the increased cardiovascular risk [1] .
comorbidities, and the increased prevalence of geriatric syndromes, such as cognitive and physical dysfunction, leading to increased risk of nursing home admission by threefold [2] .
Because of the complexity of diabetes in old age and the heterogeneous nature of this age group, comprehensive geriatric assessment is important on the initial examination of older people with diabetes with an individualized goal of therapy aiming to prevent loss of autonomy, and preserve independence and quality of life. This article reviews the management of type 2 diabetes in old age with a focus on various aspects relevant to older people.
METHODS

The authors performed a search of Medline and
Embase from January 1969 to March 2013 using keywords relating to diabetes management in older people. Only English language articles were selected. Articles were reviewed for relevance by abstract. A manual review of citations in retrieved articles was performed in addition to the electronic literature search. The final list of cited references was chosen on the basis of scientific quality and relevance to the topic of review.
EPIDEMIOLOGY
The increasing prevalence of obesity and global aging of the population implies that the incidence and prevalence of diabetes will continue to rise. The worldwide prevalence of diabetes will double from the year 2000-2030,
with the greatest increase in those [65 years of age [3] . In France between 2000 and 2009, the prevalence increased with age to 14.2% in those aged 65-74 years, peaking at 19.7% in men and 14.2% in women aged 75-79 years [4] . In the US, total diabetes prevalence is estimated to be 14% of the population and is highest in those aged C65 years, and by the year 2050 diabetes prevalence could be as high as 33% [5] . However, the prevalence of undiagnosed diabetes remains high. In the National Health and Nutrition Examination Survey (NHANES), the prevalence of diagnosed diabetes in those C75 years old was 14.9%, and undiagnosed diabetes based on fasting plasma glucose and [9] . For the oldest residents (aged C85 years), the prevalence increased from 13.1-19.5% in males (P = 0.02) and from 11.3-16.1% in females (P = 0.04) [9] . A more recent survey showed a further increase in the prevalence affecting approximately 32.8% of residents [10] .
ETIOLOGY
Normal glucose homeostasis requires both normal insulin secretion by beta cells of the pancreas and normal peripheral glucose utilization by peripheral tissues sensitive to insulin. In old age, increased adiposity and decreased physical activity predispose older people to develop insulin resistance [11] . As the muscle tissue is the main site of glucose consumption, the loss of muscle mass or sarcopenia associated with aging increases the risk of developing insulin resistance, glucose intolerance, and diabetes [12] . Aging is also associated with impaired insulin secretion [13] . [21] . The mortality rate reported from this study was high (34%) after 1-year of follow-up, indicating severe disability and frailty [22] . In another study, residents with diabetes had a greater comorbidity burden (Hierarchical Condition Category 1.90 versus 1.58), more prescribed medications, and experienced more hospitalizations (37% versus 18%) than residents without diabetes [10] . This increased comorbidities in older people with diabetes could be related to the improved survival and decreased cardiovascular mortality [23] .
GERIATRIC SYNDROMES
Geriatric syndromes, such as cognitive and physical dysfunction, depression, and falls and urinary incontinence, are common in older people with diabetes and may have subtle presentations [24] . Due to the effect of diabetes on physical function the risk of disability in performing activities of daily living is increased by twofold compared to those without diabetes [25] . Diabetes is also associated with reduced muscle strength, poor muscle quality, accelerated loss of lower extremity strength, and muscle mass contributing further to physical limitation and frailty [26] . Frailty can be defined as a condition in which an older person is coping just above the threshold of disability; therefore, any physical or psychological stress can lead to loss of independence and overt disability [27] . Diabetes mellitus and insulin resistance increase the likelihood of accelerated aging process and development of frailty [28] . Diabetes complications may contribute to worsening of geriatric syndromes, such as increased risk of falls due to peripheral neuropathy or impaired vision caused by diabetic retinopathy. Unlike other chronic conditions, diabetes care is dependent on the patients' ability to perform self-care tasks, which may be compromised by both cognitive and physical disability. For example, patients with cognitive impairment may not be able to recognize or treat hypoglycemia, or remember and administer their insulin regime correctly. Also, patients with depression may have problems with medication or self-care compliance leading to persistent hyperglycemia and increased risk of diabetic complications [29] .
GUIDELINES EVIDENCE
Guidelines for the management of diabetes in old age do not have the same evidence-base as those for younger diabetic populations due to the exclusion of older people from clinical trials.
Evidence for Glycemic Control
Tight glycemic control reduces microvascular disease. However, the UK Prospective Diabetes Study (UKPDS) is the only study that showed benefit in reducing macrovascular disease [30] .
The more recent randomized controlled trials [31] [32] [33] have failed to show a benefit of tight glycemic control in reducing macrovascular complications, and mortality rate was significantly higher in the intensive therapy arm of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial (5% versus 4%) [31] . The lack of benefit on macrovascular risk reduction in these trials could be explained by the relatively older population, longer duration of diabetes, and the high prevalence of already established cardiovascular disease (32-40%); thus, minimizing the benefit of tight glycemic control. On the other hand, the UKPDS population was relatively younger and the study had included only patients with newly diagnosed diabetes and excluded those with significant cardiovascular disease ( Table 1 [30-33]).
Evidence for Older People
Currently, there is no evidence to suggest that tight glycemic control will have a positive impact on outcomes relevant to older people, such as a delay in cognitive decline or disability [34, 35] . In fact, low HbA1c \53 mmol/mol (\7%) has been shown to increase risk of falls [36] . In frail older patients, the presence of competing comorbidities means that life expectancy and quality of life may be reduced more by other conditions than by diabetes. In a decision analysis to assess the effects of baseline health status on prioritization of intensive control of glucose and blood pressure levels in older patients with type 2 diabetes, intensive blood pressure control conferred a larger benefit than glucose control at advanced ages (75-79 years old), and the expected benefits of both therapies steadily declined as the level of comorbid illness and functional impairment increased [37] . Therefore, guidelines generally recommend strict glucose control in healthier older patients and lax approach in frail patients with multiple comorbidities and high risk of hypoglycemia [38] .
MANAGEMENT
Diabetes management of older people should take into account their heterogonous nature, complex needs, and targets relevant to them should be addressed at the outset considering their goals and wishes, particularly quality of life.
Initial Assessment
Older people with diabetes should have a comprehensive geriatric assessment on (Table 2 [39]).
Life Style Modification and Drug Therapy
Healthy life style modifications, such as weight reduction in overweight patients, regular exercise, and smoking cessation, are similarly beneficial in older people as they are in younger people. Cardiovascular mortality risk remains high even in older people ([75 years old) with diabetes; therefore, cardiovascular risk Table 2 Comprehensive geriatric assessment for older people with diabetes [39] A. Microvascular complications Retinopathy Screening for diabetic retinopathy as well as other ocular diseases common in older people, such as cataract, glaucoma, and macular degeneration. Preservation of vision is important to prevent social isolation, reduce incidence of falls, and maintain independence especially for self-medication with insulin Nephropathy Chronic kidney disease is common in older people. Monitoring of renal function is essential for adjustment of medications. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers should be used in patients with persistent microalbuminuria Neuropathy Regular feet inspection and access to diabetic foot care is essential in older people with diabetes as many may not be able to care for their feet due to physical disability B. Cardiovascular risk factors Cardiovascular disease is the most common cause of mortality in patients with diabetes regardless of age. Life style modification, such as weight reduction, regular exercise, and smoking cessation, is recommended. Achieving blood pressure and blood glucose control is essential along with dyslipidemia treatment and the use of antiplatelets as a secondary prevention 
Glycemic Targets
Due to heterogeneity of older people with diabetes, glycemic targets should be individualized taking into consideration the individuals' overall health and life expectancy.
Fit Older People
For healthier older people with low prevalence of cardiovascular risk factors, especially those with a new diagnosis of diabetes, tight glycemic control with a HbA1c approximately 53 mmol/ mol (7%) is reasonable. The UKPDS follow-up study showed the benefit of improved glycemic control on lowering cardiovascular events in newly diagnosed patients with diabetes and low prevalence of cardiovascular disease [30] . Also, it has been shown that persistent hyperglycemia is associated with the increased risk of mortality [41] and falls [42] regardless of the associated comorbidities. 
Frail Older People
Very Frail Older People
For very frail older people, and those residents in nursing homes and with a limited life expectancy, a target HbA1c of 64-75 mmol/ mol (8-9%) is appropriate. Tight glycemic control in this population may be harmful by inducing hypoglycemia and reducing quality of life. Also, higher HbA1c[75 mmol/mol ([9.0%) has been shown to be associated with increased mortality [43] . Targets in this population should focus on short-term day-to-day blood glucose levels rather than a long-term HbA1c, due to limited life expectancy, to avoid both hyperglycemia, which may lead to lethargy, dehydration, visual impairment, and infections and hypoglycemia, which may lead to falls and confusion ( Fig. 1) .
Considerations in Older People
Care Homes Care home residents with diabetes are likely to be frail, with multiple comorbidities and limited life expectancy. Therefore, short-term glycemic targets with minimal diabetes-related interventions are more important to maintain quality of life. Maintaining a random blood glucose [4 but \15 mmol/L is a reasonable target as blood glucose outside this range is likely to be symptomatic and results in cognitive changes [44] . Maintaining blood glucose in this ''comfort zone'' may insure ''comfort care'' avoiding both hyperglycemia [50] . This is important as it may alert the clinicians to screen for cognitive dysfunction if patients' noncompliance with self-care task is observed or recurrent unexplained hypoglycemia occurs. Clinicians should also be aware that dementia may be associated with language impairment, disorientation, and personality changes, which may mimic the symptoms of hypoglycemia [51] .
Older people with diabetes and dementia will have complex needs due to increased dependency and unpredictable behavioral changes as the decline in cognitive function continues. For example, hydration should be maintained due to impaired thirst sensation to avoid risk of volume depletion and hyperglycemic crises. In insulin-treated patients, the new class of long-acting insulin analogs may be a good option as they reduce the risk of hypoglycemia and can be conveniently injected once-daily [52] . Patients who have erratic eating patterns and unpredictable caloric intake could be managed with a regime where short-acting insulin analogs are administered only after meal consumption; thus, preventing insulin-induced hypoglycemia if a meal is missed or only partly consumed.
Hypoglycemia
Older people with diabetes are at increased risk of hypoglycemia even at a comparable glycemic control to younger people due to the associated multiple comorbidities [53, 54] . Older patients may tolerate low blood glucose with no specific symptoms due to diminished autonomic response with old age. Therefore, it is important that patients and carers are educated to recognize the symptoms and to treat hypoglycemia. Educational programs should be adapted to patients' and carers' abilities.
Medications should be reviewed to switch patients taking longer-acting sulfonylureas into shorter-acting agents and polypharmacy reviewed regularly. 
Quality of Life
